Current SATVI news
Read the latest news about the fight against TB in the Cape Winelands.
Read about news in the fight against TB. Lees nuus oor die stryd teen TB.
SATVI will be launching the "Tb Under the Spotlight Science Engagement" in partnership with the Department of Education, the SA MRC Centre for Tuberculosis Research, the DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Stellenbosch University and UCT Anthropology on Tuesday 20 March 2018 in Worcester, Stellenbosch, and Robertson.
We have a vacancy for a Research Pharmacist at our Worcester Field site. NOW CLOSED
On Friday 17 November 75 ministers announced a landmark agreement to take urgent action to end tuberculosis (TB) by 2030 at the conclusion of a World Health Organization (WHO) conference in Moscow, Russia, on eradicating the world's deadliest infectious disease.
Associate Professor Tom Scriba has collaborated with the authors of a research paper titled: "TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development" appearing in the Frontiers in Immunology Journal.
Associate Professor Tom Scriba has co authored a research paper titled "Polyfunctional CD4+T Cells as targets for Tuberculosis Vaccination" appearing in the Frontiers in Immunology Journal.
SATVI authors Dr Elisa Nemes, Prof Mark Hatherill, Associate Prof Tom Scriba, Dr Michele Tameris, Humphrey Mulenga and Danelle Van As have published a research paper titled: "Safety and Immunogenicity of newborn MVA 85 A vaccination and selective delayed Bacille Calmette-Guerin for infants of HIV infected mothers: a Phase 2 randomized controlled trial" appearing in the Infectious Disease Journal (Oxford).
Associate Professor Tom Scriba has co-authored a article titled: "Host blood RNA predict the outcome of tuberculosis treatment" appearing in the Tuberculosis Journal.
SATVI invites applications for the position of Research Officer: Systems Immunology at its Cape Town offices. CLOSED.
SATVI authors have published a research paper titled: "Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population" appearing in the PLoS ONE Journal.
Professor Mark Hatherill and Associate Professor Tom Scriba have co-authored a research paper titled "A Functional Toll-interacting Protein variant with Bacillus Calmette-Guerin specific immune responses and Tuberculosis" appearing in the American Journal of Respiratory and Critical Care Medicine.